Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Octreotide acetate preparation (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Octreotide acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Octreotide acetate 100mcg/mL injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Octreotide acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Octreotide acetate 500mcg/mL injection (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Octreotide acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Octreotide acetate 200mcg/mL injection (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Octreotide acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Octreotide acetate 10mg (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Octreotide acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Octreotide acetate 20mg depot injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Octreotide acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Octreotide acetate 30mg (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Octreotide acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Octreotide acetate 50mcg/mL injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Octreotide acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Octreotide acetate 1mg/mL injection (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Octreotide acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Octreotide 500micrograms/mL injection solution 1mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Octreotide acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Octreotide 1mg/mL injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Octreotide acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Octreotide 1mg/5mL injection (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Octreotide acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Octreotide 100micrograms/1mL injection (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Octreotide acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Octreotide 50micrograms/mL injection solution 1mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Octreotide acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely octreotide (as octreotide acetate) 10 milligram/1 vial powder for conventional release suspension for injection (clinical drug) |
Has precise active ingredient |
True |
Octreotide acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely octreotide (as octreotide acetate) 20 milligram/1 vial powder for conventional release suspension for injection (clinical drug) |
Has precise active ingredient |
True |
Octreotide acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Octreotide (as octreotide acetate) 30 mg powder for suspension for injection vial |
Has precise active ingredient |
True |
Octreotide acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely octreotide (as octreotide acetate) 100 microgram/1 milliliter conventional release solution for injection ampule |
Has precise active ingredient |
False |
Octreotide acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely octreotide (as octreotide acetate) 1 milligram/5 milliliter conventional release solution for injection vial |
Has precise active ingredient |
False |
Octreotide acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely octreotide (as octreotide acetate) 500 microgram/1 milliliter conventional release solution for injection ampule |
Has precise active ingredient |
False |
Octreotide acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely octreotide (as octreotide acetate) 50 microgram/1 milliliter conventional release solution for injection ampule |
Has precise active ingredient |
False |
Octreotide acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely octreotide (as octreotide acetate) 200 microgram/1 milliliter conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Octreotide acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely octreotide (as octreotide acetate) 500 microgram/1 milliliter conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Octreotide acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Octreotide (as octreotide acetate) 50 microgram/mL solution for injection |
Has precise active ingredient |
True |
Octreotide acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely octreotide (as octreotide acetate) 100 microgram/1 milliliter conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Octreotide acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |